vs
HUDSON TECHNOLOGIES INC（HDSN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是HUDSON TECHNOLOGIES INC的1.7倍（$75.5M vs $44.4M），HUDSON TECHNOLOGIES INC同比增速更快（28.2% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-33.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -17.5%）
哈德逊科技是总部位于美国的可持续制冷剂解决方案供应商，提供原生及回收再生制冷剂、制冷剂回收处理和合规支持服务，主要服务北美市场，核心客户覆盖暖通空调、商用制冷和工业冷却领域，助力客户向低全球变暖潜能值制冷剂转型。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HDSN vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$44.4M
营收增速更快
HDSN
高出0.5%
27.7%
自由现金流更多
PBYI
多$48.0M
$-33.7M
两年增速更快
PBYI
近两年复合增速
-17.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.4M | $75.5M |
| 净利润 | $-8.6M | — |
| 毛利率 | 8.0% | 69.3% |
| 营业利润率 | -25.2% | 22.7% |
| 净利率 | -19.4% | — |
| 营收同比 | 28.2% | 27.7% |
| 净利润同比 | -236.6% | — |
| 每股收益（稀释后） | $-0.19 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HDSNPBYI
| Q4 25 | $44.4M | $75.5M | ||
| Q3 25 | $74.0M | $54.5M | ||
| Q2 25 | $72.8M | $52.4M | ||
| Q1 25 | $55.3M | $46.0M | ||
| Q4 24 | $34.6M | $59.1M | ||
| Q3 24 | $61.9M | $80.5M | ||
| Q2 24 | $75.3M | $47.1M | ||
| Q1 24 | $65.3M | $43.8M |
净利润HDSNPBYI
| Q4 25 | $-8.6M | — | ||
| Q3 25 | $12.4M | $8.8M | ||
| Q2 25 | $10.2M | $5.9M | ||
| Q1 25 | $2.8M | $3.0M | ||
| Q4 24 | $-2.6M | — | ||
| Q3 24 | $7.8M | $20.3M | ||
| Q2 24 | $9.6M | $-4.5M | ||
| Q1 24 | $9.6M | $-4.8M |
毛利率HDSNPBYI
| Q4 25 | 8.0% | 69.3% | ||
| Q3 25 | 32.0% | 77.7% | ||
| Q2 25 | 31.3% | 76.5% | ||
| Q1 25 | 21.8% | 77.1% | ||
| Q4 24 | 16.7% | 76.4% | ||
| Q3 24 | 25.7% | 63.9% | ||
| Q2 24 | 30.0% | 77.4% | ||
| Q1 24 | 32.8% | 75.5% |
营业利润率HDSNPBYI
| Q4 25 | -25.2% | 22.7% | ||
| Q3 25 | 18.9% | 17.6% | ||
| Q2 25 | 17.5% | 12.7% | ||
| Q1 25 | 5.6% | 8.7% | ||
| Q4 24 | -9.4% | 22.6% | ||
| Q3 24 | 11.3% | 27.4% | ||
| Q2 24 | 17.0% | -4.6% | ||
| Q1 24 | 19.6% | -5.3% |
净利率HDSNPBYI
| Q4 25 | -19.4% | — | ||
| Q3 25 | 16.7% | 16.2% | ||
| Q2 25 | 14.0% | 11.2% | ||
| Q1 25 | 5.0% | 6.5% | ||
| Q4 24 | -7.4% | — | ||
| Q3 24 | 12.6% | 25.2% | ||
| Q2 24 | 12.7% | -9.6% | ||
| Q1 24 | 14.7% | -11.0% |
每股收益（稀释后）HDSNPBYI
| Q4 25 | $-0.19 | $0.26 | ||
| Q3 25 | $0.27 | $0.17 | ||
| Q2 25 | $0.23 | $0.12 | ||
| Q1 25 | $0.06 | $0.06 | ||
| Q4 24 | $-0.05 | $0.40 | ||
| Q3 24 | $0.17 | $0.41 | ||
| Q2 24 | $0.20 | $-0.09 | ||
| Q1 24 | $0.20 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $243.4M | $130.3M |
| 总资产 | $318.6M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HDSNPBYI
| Q4 25 | $39.5M | $97.5M | ||
| Q3 25 | $89.7M | $94.4M | ||
| Q2 25 | $84.3M | $96.0M | ||
| Q1 25 | $81.0M | $93.2M | ||
| Q4 24 | $70.1M | $101.0M | ||
| Q3 24 | $56.5M | $96.7M | ||
| Q2 24 | $30.5M | $96.8M | ||
| Q1 24 | $10.6M | $107.2M |
总债务HDSNPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HDSNPBYI
| Q4 25 | $243.4M | $130.3M | ||
| Q3 25 | $265.9M | $115.3M | ||
| Q2 25 | $254.8M | $104.7M | ||
| Q1 25 | $246.8M | $97.1M | ||
| Q4 24 | $245.8M | $92.1M | ||
| Q3 24 | $253.9M | $71.1M | ||
| Q2 24 | $248.7M | $48.5M | ||
| Q1 24 | $238.6M | $51.0M |
总资产HDSNPBYI
| Q4 25 | $318.6M | $216.3M | ||
| Q3 25 | $338.9M | $202.9M | ||
| Q2 25 | $317.9M | $194.9M | ||
| Q1 25 | $307.9M | $196.2M | ||
| Q4 24 | $302.7M | $213.3M | ||
| Q3 24 | $309.4M | $220.7M | ||
| Q2 24 | $300.9M | $205.0M | ||
| Q1 24 | $294.2M | $214.1M |
负债/权益比HDSNPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-33.7M | $14.4M |
| 自由现金流率自由现金流/营收 | -75.8% | 19.1% |
| 资本支出强度资本支出/营收 | 2.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.2M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HDSNPBYI
| Q4 25 | $-32.5M | $14.4M | ||
| Q3 25 | $8.8M | $9.7M | ||
| Q2 25 | $6.4M | $14.1M | ||
| Q1 25 | $14.2M | $3.6M | ||
| Q4 24 | $20.7M | $15.6M | ||
| Q3 24 | $30.3M | $11.0M | ||
| Q2 24 | $41.8M | $1.0M | ||
| Q1 24 | $-933.0K | $11.2M |
自由现金流HDSNPBYI
| Q4 25 | $-33.7M | $14.4M | ||
| Q3 25 | $6.7M | $9.7M | ||
| Q2 25 | $5.9M | $14.1M | ||
| Q1 25 | $12.7M | $3.6M | ||
| Q4 24 | $19.2M | $15.6M | ||
| Q3 24 | $28.6M | $11.0M | ||
| Q2 24 | $40.6M | $1.0M | ||
| Q1 24 | $-1.9M | — |
自由现金流率HDSNPBYI
| Q4 25 | -75.8% | 19.1% | ||
| Q3 25 | 9.1% | 17.7% | ||
| Q2 25 | 8.2% | 26.8% | ||
| Q1 25 | 23.0% | 7.7% | ||
| Q4 24 | 55.3% | 26.4% | ||
| Q3 24 | 46.2% | 13.7% | ||
| Q2 24 | 54.0% | 2.1% | ||
| Q1 24 | -2.9% | — |
资本支出强度HDSNPBYI
| Q4 25 | 2.5% | 0.0% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 2.5% | 0.1% | ||
| Q4 24 | 4.5% | 0.0% | ||
| Q3 24 | 2.7% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 1.5% | 0.0% |
现金转化率HDSNPBYI
| Q4 25 | — | — | ||
| Q3 25 | 0.71× | 1.10× | ||
| Q2 25 | 0.63× | 2.41× | ||
| Q1 25 | 5.13× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.88× | 0.54× | ||
| Q2 24 | 4.36× | — | ||
| Q1 24 | -0.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HDSN
| Products | $43.1M | 97% |
| Services | $1.3M | 3% |
PBYI
暂无分部数据
